Try our mobile app

ИНН: 7801557131

E-disclosure page: 39297

Рост выручки hist 0.0%
Рост EBITDA hist 0.0%


млн руб
LTM Выручка 0
LTM EBITDA 0

Interest payment 0

Revenue and EBITDA

Quarterly values (m RUB)

Change (y/y)

Cash Flow

FCF (m RUB), before FX effects elimination

Net Debt / Cash and Equivalents (m RUB)

Облигации
Название ISIN Тип Доходность Валюта Цена Объем торгов (млн р.) Купон Ставка купона Премия Дата погашения/оферты Дюрация, лет
БиоВит 1Р1 RU000A10B7N0 фикс +27.9% RUB 103.9% 0.63 23.0 28.0% - 2028-03-17 1.5
БиоВит 1Р2 RU000A10EQV2 фикс +23.2% RUB 104.3% 0.58 19.1 23.3% - 2029-03-17 2.5
RSBU data *The values are shown in mln. The % change shows the difference from the same period last year

View as Pivot Table       Export as Pivot Table (xlsx)



Income


Q Revenue Gross profit Operating income Net income PercentProfit PercentLoss
 
2026 q2 752-9% 2610% 83+16% 39+125% 48-30% -67-34%
2026 q1 587-2% 216-2% 45+4% -27<-100% 47-28% -79-22%
2025 q4 1 041+5% 371+13% 102+19% 37+82% 51-27% -86-20%
2025 q3 826-15% 348-1% 106-36% 32-30% 56-8% -95+7%
2025 q2 825+1% 261-15% 72+34% 17+41% 67+25% -102+23%
2025 q1 598+7% 220+44% 44>+200% 0+173% 66+49% -102+40%
2024 q4 988 329 86 20 70 -107
2024 q3 975+45% 353+44% 165>+200% 46+88% 61>+200% -89>+200%
2024 q2 815 305 53 12 54 -83
2024 q1 556 153 12 0 44 -73
2023 q4            
2023 q3 674 245 54 24 9 -28
2022 q4 792-10% 337+16% 152+56% 93+73% 3>+200% -14+78%
2021 q4 882 289 97 54 0 -8


Balance


Implied interest rate for 2026 q2:
= (PercentLoss - PercentProfit) * (365 / periodLength) / (NetDebt - MinorityInterest)
= (67 - 48) * 4 / (1 702 - 0)

Q Total equity Total assets Net debt
 
2026 q2 1 118+8% 3 635+6% 1 702+11%
2026 q1 1 079+6% 3 156+1% 1 569+4%
2025 q4 1 107+9% 3 191-1% 1 551-11%
2025 q3 1 069+7% 3 209-2% 1 545-10%
2025 q2 1 037 3 421 1 533
2025 q1 1 020 3 114 1 509
2024 q4 1 020+8% 3 217 1 749+11%
2024 q3 999 3 260 1 717
2024 q2      
2024 q1      
2023 q4 941+7%   1 573>+200%
2023 q3      
2022 q4 877 1 766 414+52%
2021 q4     272

RAS reports